Beskrivning
Patients afflicted with SARS-CoV-2, Influenza A (Flu A), Influenza B (Flu B), and/or Respiratory Syncytial Virus (RSV) often exhibit similar symptoms, yet necessitate distinct approaches to management. The SARS-CoV-2, Flu A/B, and RSV qualitative test streamlines the rapid triage and patient management process, swiftly identifying various viruses in under 1 hour.
This panel enables healthcare professionals to administer pathogen-specific treatments and targeted interventions effectively. By combining these tests, healthcare facilities not only streamline costs but also address the complexities of respiratory infections directly at the point of care. This integrated approach facilitates infection control measures and enhances risk assessment, ultimately contributing to more efficient and tailored patient care.
